Eugene Sefanov

  This struck me as interesting: The Boston Globe wrote an article on how doctors at Brigham and Women’s Hospital (BWH) are encouraged to share medical errors. In fact, they are asked to do so, knowing that the information will be published in a case study-like format for the public to see. The objective is […]

  As a user of 23andMe since 2008, I’ve been closely following the company, especially since the FDA told them in 2013 to stop marketing their personal genetics testing service. At last, the FDA has given 23andMe the green light. Not surprisingly, the positive news pushed the cost of the genetics test from $99 to […]

  Read this TechCrunch article. Make sure your company’s executives read it, too. According to Google, for the first time ever, more people are performing Google searches on their mobile phones than on their computers. If that doesn’t tell you the digital landscape has changed, I’m not sure what will make you believe it. 

  I’ve written a number of blog posts on the challenges of clinical trial recruitment, and that’s for good reason. According to Dr. Steven Alberts, Chair of Medical Oncology with the Mayo Clinic, only 5% of cancer patients ever enroll in a trial. On top of that, only a fraction of all trials ever complete […]

  According to Jack Bogle, the founder and retired CEO of The Vanguard Group, many large companies based in the U.S. generate 50% of their revenue from outside the country. The same could be said for international companies: a good portion of their revenue is generated outside their respective regions. 

  Last week, Perficient announced that it purchased Rise Foundation, a pre-configured and enhanced version of Microsoft SharePoint, from Blue Rooster. Rise Foundation provides companies with an intranet solution that has the look and feel users expect in today’s digital world. In addition to the impressive UI, the solution enables companies to be more productive […]

  A couple of weeks ago, I shared some statistics that I learned from an FDA blog post about rare diseases. While those numbers will make you cringe, Pfizer will give you hope. They, along with Spark Therapeutics, are teaming up to develop treatments for rare diseases, like hemophilia, through gene therapy. Gene therapy is […]

  Last week, I attended a webinar that showcased the results of a study on the adoption of clinical trial software in life sciences. The study was conducted by a working group led by the Tufts Center for the Study of Drug Development, CDISC, and Oracle Health Sciences, and the results reiterated what we already […]

  A few days ago, I read an article in The Atlantic about precision medicine. But it wasn’t about developing drugs for individuals with specific biomarkers. Instead, it discussed a simpler form of precision medicine that can prevent serious adverse events (SAEs). This method can actually fit in your wallet. It’s a card that houses […]

  Oracle recently created a short video that explains what Data Management Workbench (DMW) is all about. In short, DMW is an application that is part of Oracle’s clinical data warehousing suite that’s designed to combine data from various data sources and third-party providers, and transform it into standard data models. In addition to the […]

  On September 24, 2015, the FDA issued a Warning Letter to a manufacturer and distributor of medical devices for several violations. While the issues at hand may not seem severe, they do put the public at risk and reduce the confidence that the FDA has in the organization. Plus, they are inviting unwanted scrutiny […]

  And that was just this past year. So, I think it’s fair to say that Oracle’s software is the cream of the crop in the life sciences and healthcare industries. According to a press release issued by the company, close to 100 life sciences companies have signed on to use Oracle’s clinical and safety […]